CTABF - Canntab Therapeutics enters strategic partnership with Levitee Clinics
Canntab Therapeutics (OTCQB:CTABF) has entered into a service agreement with Levitee Clinics. Levitee aims to transform mental health and addiction treatments through the integration of alternative medicinal therapies. Agreement with Levitee to service over 35,000 annual patient visits with the aim to help treat their patients with substance use addictions and chronic pain Levitee Labs will offer the entire Canntab product lineup throughout all its clinics and pharmacies in Alberta and British Columbia
For further details see:
Canntab Therapeutics enters strategic partnership with Levitee Clinics